During the past decade, Kanazawa Cardiovascular Hospital conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Kanazawa Cardiovascular Hospital" are "Chronic Heart Failure" (1 trials) and "Vascular Stent-Graft Stenosis" (1 trials). Many other conditions were trialed in "Kanazawa Cardiovascular Hospital" in a lesser frequency.

Most popular intervention types in "Kanazawa Cardiovascular Hospital" are "Device" (1 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Bisoprolol" (1 trials), "Carvedilol" (1 trials) and "GORE® VIABAHN® Stent Graft" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kanazawa Cardiovascular Hospital" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Kanazawa Cardiovascular Hospital". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Kanazawa Cardiovascular Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kanazawa Cardiovascular Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".